ospemifene) for the treatment of moderate to severe vaginal dryness
, a symptom of vulvovaginal atrophy (VVA), due to menopause.
This information should be seen as very reassuring to women who need to take hormone therapy to treat menopausal symptoms, such as hot flushes, insomnia, or vaginal dryness
As a result, the vaginal surrounding tissues widen causing, dryness, loss of libido, and certain vaginal atrophy symptoms such as itching, burning sensation or soreness or painful sex due to vaginal dryness
How it affects you: Vaginal dryness
can be uncomfortable, leaving you more vulnerable to irritation or pain during sex.
Furthermore, half of them (50%) experience vaginal dryness
with or without pain during sex.
The second human clinical trial found Estro-G100 to significantly improve night sweats, hot flashes, vaginal dryness
, insomnia, depression and joint discomfort in 61 menopausal participants over 3 months (also utilizing the KMI).
4 ( ANI ): A study has suggested that changing bacterial mix in vagina could lead to vaginal dryness
and sexual pain after menopause.
Statistically significant improvement in vaginal dryness
in the EstroG-100 group was also observed compared with that of the placebo group (p < 0.
A novel selective estrogen-receptor modulator called ospemifene was more effective than placebo for reducing symptoms of vaginal dryness
and dyspareunia in a study of 919 postmenopausal women.
The symptoms include gritty, irritated eyes, dry mouth and difficulty swallowing, fatigue, joint pain and vaginal dryness
Subjects covered include hot flashes, early menopause, hormone replacement therapy, cancer, exercise, lifestyle choices, memory loss, and vaginal dryness
Symptoms were recorded using a questionnaire that assessed vaginal bleeding or spotting, vaginal dryness
and intention to continue the medications.